Quarterly report pursuant to Section 13 or 15(d)

SHARE-BASED COMPENSATION

v3.22.2
SHARE-BASED COMPENSATION
6 Months Ended
Jun. 30, 2022
SHARE-BASED COMPENSATION  
SHARE-BASED COMPENSATION

NOTE 6 – SHARE-BASED COMPENSATION

While the Company was a limited liability company in its pre-IPO phase of corporate development, the Company granted performance-based awards of restricted Class A Membership Interests to board members and corporate advisory council members in exchange for services. All of these awards of membership interests became fully vested upon consummation of the Company’s corporate conversion from a Delaware limited liability company to a Delaware corporation immediately prior to the Company’s IPO in June 2021, with the Company recognizing all previously unrecognized compensation expense. The fair value of the membership interests granted during 2020 and 2019 was equal to the per-membership interest value of the most recent private placement. Total share-based compensation associated with these awards had been recorded as general and administrative expenses in the amount of $563,889 and $755,556 for the three and six months ended June 30, 2021, respectively.

In April 2021, the board of directors approved the creation of the 2021 Equity Incentive Plan (the “Plan”). The Plan became effective as of the completion of the corporate conversion, with an annual evergreen provision pursuant to the Plan. The Plan currently reserves an aggregate of 2,408,631 shares of common stock, subject to adjustments as provided in the Plan, of which 537,936 are currently still available for issuance. The purpose of the Plan is to attract, retain and incentivize directors, officers, employees, and consultants.

In June 2021, the Company granted stock options to purchase a total of 807,500 shares of common stock to its three executives and three non-employee management team members to replace the Class B Membership Interests that were cancelled in March 2021. The options were issued at an exercise price of $6.26, with the employee options vesting 40% upon issuance and the balance over 36 months, and the non-employee options vesting at grant date. The Company recorded general and administrative expense of $181,720 and $363,440 for the three and six months ended June 30, 2022, and $1,655,885 for the three and six months ended June 30, 2021, related to compensation expense for these options.

In the second quarter of 2021, the Company entered into a number of agreements with vendors pursuant to which the Company granted a total of 175,000 shares of common stock, cash payments in the amount of $343,500 and 100,000 options which were included as a part of the July 2021 grant. These contracts have terms which range from six months to three years. The common stock was valued based on the grant date fair value and the options valued utilizing Black-Scholes option pricing model. The cash payments were expensed over the service period and the equity component expensed consistent with the contractual vesting. The Company recorded general and administrative expense of $1,095,500 for the three and six months ended June 30, 2021 and $0 for the three and six months ended June 30, 2022, respectively related to compensation expense for these shares.

In July 2021, the Company granted stock options to purchase a total of 1,550,000 shares of common stock to its three executives pursuant to their respective employment agreements, the independent directors, and one consultant, pursuant to the Plan. The options were issued at an exercise price of $6.18, the grant date fair value, with one-quarter of the executive’s options vesting upon issuance and the balance over 36 months, and the options granted to the directors and consultants vesting over 36 months. The Company recorded general and administrative expenses of $490,917 and $981,833 for the three and six months ended June 30, 2022 related to compensation expense for these options.

In January 2022, the Company granted stock options to purchase a total of 80,000 shares of common stock to seven consultants pursuant to the Plan. The options were issued at an exercise price of $4.44, the grant date fair value, with one-quarter of the options vesting upon issuance and the balance over 36 months. The Company recorded general and administrative expenses of $18,950 and $107,383 for the three and six months ended June 30, 2022 related to compensation expense for these options.

In April 2022, the Company granted stock options to purchase a total of 30,000 shares of common stock to a new employee pursuant to the Plan. The options were issued at an exercise price of $3.79, the grant date fair value, with one-quarter of the options vesting upon issuance and the balance over 36 months. The Company recorded general and administrative expenses of $25,095 for the three and six months ended June 30, 2022, related to compensation expense for these options.

Compensation expense associated with these awards is recognized over the vesting period based on the fair value of the option at the grant date determined based on the Black-Scholes model. Option valuation models require the input of highly subjective assumptions including the expected price volatility. The Company’s employee stock options have characteristics significantly different from those of traded options, and changes in the subjective input assumptions can materially affect the fair value computation using the Black-Scholes option pricing model. Because there is no public market for the Company’s stock options and very little historical experience with the Company’s stock, similar public companies were used for the comparison of volatility and the dividend yield. The risk-free rate of return was derived from U.S. Treasury notes with comparable maturities.

The Company determined the fair value of the option awards using the Black-Scholes option pricing model using the following weighted average assumptions:

    

Six Months Ended

 

    

June 30, 2022

 

Expected term

 

9 years

Volatility

 

90

%

Dividend yield

 

%

Risk-free interest rate

 

2.01

%

Weighted average grant date fair value

$

3.54

A summary of the Company’s stock option activity is as follows:

    

Six Months Ended

    

Weighted Average

    

June 30, 2022

    

Exercise Price

Outstanding at the beginning of the period

 

2,357,500

 

$

6.21

Granted

 

110,000

$

4.26

Vested

 

(1,253,250)

$

6.16

Outstanding and expected to vest

 

1,214,250

$

6.08

The total compensation expense not yet recognized as of June 30, 2022 was $5,637,855. The weighted average vesting period for the unvested options is 2.03 years. The intrinsic value of the stock options as of June 30, 2022 was $0, with a remaining weighted average contractual life of 9.03 years. The weighted average grant date fair value for all options is $4.67 as of June 30, 2022. The Company records the impact of any forfeitures of options as they occur.